Literature DB >> 11000485

Cloning and localization of the hyperpolarization-activated cyclic nucleotide-gated channel family in rat brain.

L M Monteggia1, A J Eisch, M D Tang, L K Kaczmarek, E J Nestler.   

Abstract

Rhythmic firing in brain and heart is mediated by pacemaker channels that are activated by hyperpolarization and regulated directly by cyclic nucleotides. Recent work has identified a new gene family that encodes such channels, which are termed hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels. In this study, we report the molecular cloning and localization by in situ hybridization of HCN1-4 in adult rat brain. The rat HCN1-4 clones show high homology to the deduced amino acid sequence of the mouse channels (>97% identity). The mRNA expression of the four channels in adult brain was evaluated in a systematic manner from the olfactory bulb to lower brain stem nuclei. Each mRNA demonstrated a unique pattern of distribution. HCN1 expression is highly enriched in cerebral cortex, hippocampus, cerebellum, and facial motor nucleus; HCN2 is highly abundant in mamillary bodies, pontine nucleus, ventral cochlear nucleus, and nucleus of the trapezoid body; HCN3 expression is most pronounced in supraoptic nucleus of hypothalamus; and HCN4 expression is most abundant in medial habenula and anterior and principal relay nuclei of the thalamus. These variations in regional specificity of HCN channels could generate important differences in neuronal pacemaker activity across brain systems.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11000485     DOI: 10.1016/s0169-328x(00)00155-8

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  85 in total

1.  Determinants of activation kinetics in mammalian hyperpolarization-activated cation channels.

Authors:  T M Ishii; M Takano; H Ohmori
Journal:  J Physiol       Date:  2001-11-15       Impact factor: 5.182

2.  Differential and age-dependent expression of hyperpolarization-activated, cyclic nucleotide-gated cation channel isoforms 1-4 suggests evolving roles in the developing rat hippocampus.

Authors:  R A Bender; A Brewster; B Santoro; A Ludwig; F Hofmann; M Biel; T Z Baram
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

3.  Postnatal development of the hyperpolarization-activated excitatory current Ih in mouse hippocampal pyramidal neurons.

Authors:  Dmitry V Vasilyev; Michael E Barish
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

4.  Convergent and reciprocal modulation of a leak K+ current and I(h) by an inhalational anaesthetic and neurotransmitters in rat brainstem motoneurones.

Authors:  Jay E Sirois; Carl Lynch; Douglas A Bayliss
Journal:  J Physiol       Date:  2002-06-15       Impact factor: 5.182

5.  Assessing the role of Ih channels in synaptic transmission and mossy fiber LTP.

Authors:  Vivien Chevaleyre; Pablo E Castillo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

6.  KCNE2 modulates current amplitudes and activation kinetics of HCN4: influence of KCNE family members on HCN4 currents.

Authors:  Niels Decher; Florian Bundis; Rolf Vajna; Klaus Steinmeyer
Journal:  Pflugers Arch       Date:  2003-07-10       Impact factor: 3.657

7.  Role of the hyperpolarization-activated cation current (Ih) in pacemaker activity in area postrema neurons of rat brain slices.

Authors:  Makoto Funahashi; Yoshihiro Mitoh; Atsushi Kohjitani; Ryuji Matsuo
Journal:  J Physiol       Date:  2003-08-01       Impact factor: 5.182

Review 8.  Exploring HCN channels as novel drug targets.

Authors:  Otilia Postea; Martin Biel
Journal:  Nat Rev Drug Discov       Date:  2011-11-18       Impact factor: 84.694

9.  Delta oscillations induced by ketamine increase energy levels in sleep-wake related brain regions.

Authors:  M Dworak; R W McCarley; T Kim; R Basheer
Journal:  Neuroscience       Date:  2011-09-17       Impact factor: 3.590

Review 10.  HCN Channel Targets for Novel Antidepressant Treatment.

Authors:  Stacy M Ku; Ming-Hu Han
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.